Advocates Across the US: An advocate in all 50 States Challenge!

Hello advocates! We need you and your voice to help continue the momentum for change in Washington, DC. In order to do this, we’re looking for an advocate (or two!) in all fifty states. Willing to help? Please let us know where you live and the names of your elected representatives. Find your elected representativesContinue reading “Advocates Across the US: An advocate in all 50 States Challenge!”

Highlights from the Herpes Cure Pipeline with Dr. Anna Wald

Highlights from the Herpes Cure Pipeline 3.0 w/ Dr. Anna Wald September 20th 6pm EST  Herpes Cure Advocacy Meet the Experts series returns this Fall with Dr. Anna Wald and an overview of the clinical pipeline for Herpes. Dr Anna Wald is Professor in the Department of Medicine, Epidemiology and Laboratory Medicine & Pathology at theContinue reading “Highlights from the Herpes Cure Pipeline with Dr. Anna Wald”

Updates from the Pipeline, IHW 2023 and more news!

Hello, The Latest News in Herpes Advocacy is here. Enjoy reading the latest news? Want to see progress faster? Support our work today. Healthy Volunteers Needed for BNT163-01 Clinical Trial Healthy volunteers sought for clinical trial for herpes vaccine candidate from BioNtech BNT-163-01. Volunteers needed near The University of Pennsylvania Hospital in Philadelphia, PA. This isContinue reading “Updates from the Pipeline, IHW 2023 and more news!”

Herpes Cure Pipeline 3.0 Release

Join the Party Herpes Cure and Treatment News At long last – the Herpes Cure Pipeline 3.0 is (almost) ready for release. To confirm your attendance, please join the wait list for the Pipeline Release Party. The Herpes Cure Pipeline is the global resource for clinical research in cure and treatment for Herpes Simplex. HerpesContinue reading “Herpes Cure Pipeline 3.0 Release”

Register: Herpes Advocates Town Hall Meeting June 1

Advocates Town Hall Meeting: Herpes advocates town hall meetings are open to patients, professionals, and those looking to get involved to make a difference. We’ll discuss Herpes Cure Advocacy urgent priorities, a 90 day action plan for new advocates, and ways to get more involved. Please submit questions in advance at info@herpescureadvocacy.com. Thursday, June 1Continue reading “Register: Herpes Advocates Town Hall Meeting June 1”

Progress for a Cure for Herpes Continues

Herpes Clinical Pipeline AiCuris Non-Confidential Slide Deck May 2023: AiCuris planning for commercial launch of Priteliver 2025. Launch prep for Priteliver is ongoing. Innovative Molecules advances IM-250: The clinical trial center in Heidelberg, Germany has Phase 2 clinical trials are scheduled for 2024. The clinical phase 1 study investigates the safety, tolerability, and pharmacokinetics ofContinue reading “Progress for a Cure for Herpes Continues”

Herpes Keratitis Cure advances to Phase 3 Clinical Trials in China

BDGene Therapeutics is a Chinese biotech company based in Shanghai. BDgene now has approval to run Phase 3 trials (held in China) on their gene therapy cure for HSV-1 keratitis. The gene editing treatment for viral keratitis (BD111), developed based on BDmRNA delivery patent technology, has completed 3 human clinical trials of IIT. It isContinue reading “Herpes Keratitis Cure advances to Phase 3 Clinical Trials in China”

NIH forms Multi-Council Working Group for Herpes

Herpes Cure Advocacy celebrates a step forward on the path to the cure, treatment and prevention of Herpes. NIH has assembled a Multi-Council Working Group for Herpes Simplex Virus and are calling for input from field scientists and the general public. Herpes patients and field experts are excited to see this progress, an important winContinue reading “NIH forms Multi-Council Working Group for Herpes”

Latest Updates on Herpes Cure Treatment and Prevention

Herpes Cure Advocacy News HHS Listening Sessions: Two listening sessions were held this past week in an effort to gather insights for an addendum to the HHS 2020 STI Strategic Plan. Both patients and providers spoke with OIDP, NIH, and CDC stakeholders about their experiences and ideas for how to help cure, treat and preventContinue reading “Latest Updates on Herpes Cure Treatment and Prevention”

Advocacy Alert: Registration Open for OASH Listening Sessions

Mark your calendars! The HHS Office of Infectious Disease and HIV/AIDS Policy (OIDP) wants to hear from members of the STI community during two virtual listening sessions on April 4th and April 6th, 2023. OIDP is developing an addendum to the STI National Strategic Plan to include herpes simplex virus (HSV) types 1 and 2 in the United States.Continue reading “Advocacy Alert: Registration Open for OASH Listening Sessions”